Predict MDE Outcomes After MST

Status Completed

Clinical Trial Summary

This trial attempts to explore the treatment outcome of magnetic seizure therapy (MST) for major depressive episode. Half of the participants will receive MST, while the other half will receive electroconvulsive therapy (ECT).

Clinical Trial Description

Magnetic seizure therapy (MST) is likely to be an alternative options to electroconvulsive therapy (ECT). Widespread stimulation of cortical and subcortical regions is inevitable for ECT since the substantial impedance of the scalp and skull shuts most of the electrical stimulus away from the brain. Nevertheless, magnetic pulses are capable to focus the stimulus to a specific area of the brain because they can pass the scalp and skull without resistance. In Addition, electric current will penetrate into deeper structures, while magnetic stimulus are only capable to reach a depth of a few centimeters. As a consequence, MST are able to generate focus stimuli on superficial regions of the cortex while ECT can't, which may give MST the capability to produce comparable therapeutic benefits with the absence of apparent cognitive side effects. ;

Study Design

Related Conditions & MeSH terms

Major Depressive Episode

Clinical Trial Details

NCT number	NCT03841019
Study type	Interventional
Source	Shanghai Mental Health Center
Contact
Status	Completed
Phase	N/A
Start date	July 20, 2020
Completion date	May 10, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03256162` - Ketamine as an Adjunctive Therapy for Major Depression	Phase 1
Completed	`NCT01944293` - Ketamine for Suicidality in Bipolar Depression	Phase 1/Phase 2
Recruiting	`NCT01441505` - A Study of Ketamine as an Antidepressant	Phase 2
Active, not recruiting	`NCT03487926` - Microglial Activation in Inflammatory Bowel Disease
Recruiting	`NCT04939649` - Ketamine as an Adjunctive Therapy for Major Depression (2)	Phase 3
Recruiting	`NCT05028738` - Patient-oriented Randomized Pragmatic Feasibility Trial With rTMS in Depression and Anxiety	N/A
Recruiting	`NCT03646058` - Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode	Phase 3
Completed	`NCT03735576` - Cognitive Behavioural Therapy for the Treatment of Late Life Depression	N/A
Recruiting	`NCT04999553` - Left vs. Right Non-Inferiority Trial	N/A
Completed	`NCT03716869` - Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder	N/A
Recruiting	`NCT02824081` - Neuroinflammation, Serotonin, Impulsivity and Suicide	N/A
Terminated	`NCT01099592` - Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression	Phase 4
Completed	`NCT03752853` - Stress Systems and Psychotherapy in Depression	N/A
Recruiting	`NCT04480918` - University of Iowa Interventional Psychiatry Service Patient Registry
Recruiting	`NCT04130958` - Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics	N/A
Completed	`NCT03190772` - The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation	N/A
Recruiting	`NCT04832750` - Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep
Terminated	`NCT02839798` - NeoSync TMS Treatment for Bipolar I Depression	Phase 2
Completed	`NCT00852592` - Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial	Phase 3
Terminated	`NCT05063604` - Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression	Phase 2